How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Bio-Rad in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
319 clearance records and 0 recall records in the covered releases, across 1 source company names and 84 product codes. Dated history runs from Jul 20, 1976 to Dec 28, 2017.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| MRSASelect IIK171061 · JSO | Bio-Rad | 510(k) | Dec 28, 2017FDA decision date |
| VRESELECT CULTURE MEDIUMK122187 · JSO | Bio-Rad | 510(k) | Nov 6, 2012FDA decision date |
| VRESELECT CULTURE MEDIUMK103684 · JSO | Bio-Rad | 510(k) | Oct 21, 2011FDA decision date |
| PLATELIA ASPERGILLUS EIA MODEL 62793K093678 · NOM | Bio-Rad | 510(k) | Jan 13, 2011FDA decision date |
| MRSA SELECT - SKIN AND SOFT TISSUE WOUND SPECIMENSK100589 · JSO | Bio-Rad | 510(k) | Oct 29, 2010FDA decision date |
| PLATELIA LYME IGMK081362 · LSR | Bio-Rad | 510(k) | Jun 26, 2008FDA decision date |
| MRSASELECT - EXTENDED INCUBATIONK081212 · JSO | Bio-Rad | 510(k) | Jun 13, 2008FDA decision date |
| PLATELIA LYME IGG ASSAYK080012 · LSR | Bio-Rad | 510(k) | May 8, 2008FDA decision date |
| MRSASELECTK070361 · JSO | Bio-Rad | 510(k) | Sep 13, 2007FDA decision date |
| PLATELIA ASPERGILLUS EIA, MODEL 62793K060641 · NOM | Bio-Rad | 510(k) | Jun 2, 2006FDA decision date |
| LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4K052838 · GGM | Bio-Rad | 510(k) | Nov 9, 2005FDA decision date |
| LIQUICHEK QUALITATIVE URINE TOXICOLOGY CONTROL, NEGATIVE, POSITIVE, MINIPAKK052053 · DIF | Bio-Rad | 510(k) | Aug 9, 2005FDA decision date |
| LIQUICHEK CARDIAC MARKERS PLUS CONTROL, LIQUICHEK CARDIAC MARKERS PLUS CONTROL LT, LIQUICHEK CARDIAC MARKERS PLUSK050537 · JJY | Bio-Rad | 510(k) | Apr 27, 2005FDA decision date |
| QUEST DIAGNOSTICS IMMUNOASSAY/TDM CONTROLK050536 · JJY | Bio-Rad | 510(k) | Mar 24, 2005FDA decision date |
| LIQUID ASSAYED MULTIQUAL CONTROLK043208 · JJY | Bio-Rad | 510(k) | Jan 7, 2005FDA decision date |
| LIQUICHEK URINE TOXICOLOGY CONTROL, (LEVELS S1S AND S2S)K042865 · DIF | Bio-Rad | 510(k) | Nov 24, 2004FDA decision date |
| QUEST TUMOR MARKER CONTROL, MODEL 955K042815 · JJY | Bio-Rad | 510(k) | Nov 5, 2004FDA decision date |
| LIQUICHEK RETICULOCYTE CONTROL (A)K042836 · JPK | Bio-Rad | 510(k) | Nov 5, 2004FDA decision date |
| LIQUICHEK ELEVATED CRP CONTROLK042837 · JJX | Bio-Rad | 510(k) | Nov 2, 2004FDA decision date |
| LYPHOCHEK ELEVATED IMMUNOSUPPRESSANT CONTROL, LEVEL 4, 5K042324 · JJY | Bio-Rad | 510(k) | Oct 7, 2004FDA decision date |
| LIQUICHEK WHOLE BLOOD VOLATILES CONTROLK041561 · DIF | Bio-Rad | 510(k) | Jul 6, 2004FDA decision date |
| LIQUICHEK HEMATOLOGY CONTROL (A)K041457 · JPK | Bio-Rad | 510(k) | Jun 28, 2004FDA decision date |
| LYPHOCHEK HEMOSTASIS CONTROLK040275 · GGN | Bio-Rad | 510(k) | Feb 27, 2004FDA decision date |
| LIQUICHEK QUALITATIVE URINE TOXICOLOGY CONTROL, NEGATIVE, MODEL 454; POSITIVE, MODEL 455K033366 · DIF | Bio-Rad | 510(k) | Dec 12, 2003FDA decision date |
| LIQUICHEK URINE TOXICOLOGY CONTROL (CONFIRMATORY SERIES)K033404 · DIF | Bio-Rad | 510(k) | Dec 12, 2003FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.